Literature DB >> 33520835

NDSP 05: Prevalence and pattern of dyslipidemia in urban and rural areas of Pakistan; a sub analysis from second National Diabetes Survey of Pakistan (NDSP) 2016-2017.

Abdul Basit1, Sobia Sabir2, Musarrat Riaz1, Asher Fawwad3,4.   

Abstract

OBJECTIVES: Dyslipidemia is a major risk issue for the development of cardiovascular disease. The aim of our study was to observe the pattern and prevalence of dyslipidemia in Pakistani population.
METHODOLOGY: This is a sub analysis of a population based second National Diabetes Survey of Pakistan (NDSP) 2016-2017 in adults aged 20 years or above, carried out from February 2016 to August 2017 across Pakistan. Multi stage sampling technique was used for the stratification of population, based on rural and urban domains. District wise clusters and sub clusters were selected i.e. 27 and 46 in number. Subjects, consented to participate were requested to come after an overnight fast for anthropometric measurements, oral glucose tolerance test and fasting lipid profile (except for subjects with self-reported diabetes). Dyslipidemia was identified using Adult Treatment Panel III guidelines.
RESULTS: A total of 10,834 subjects (43.8% male and 56.2% female) having mean age of 43.8 ± 14.0 years, participated in the survey. Of the subjects studied, 39.3% had hypercholesterolemia, 48.9% had hypertriglyceridemia, 39.7% had high LDL-C levels while 83.9% men and 90% women had low HDL levels. High cholesterol and triglyceride levels were highest in 50-59 years age group, while high LDL and low HDL was most common in 40-49 years age group. Diabetes, obesity and hypertension were found to be the significant determinants for dyslipidemia.
CONCLUSION: Prevalence of dyslipidemia seems to be very high in Pakistan, necessitating an urgent call for early screening and effective management through lifestyle intervention and appropriate lipid lowering drugs to prevent this important cardiovascular risk factor. © Springer Nature Switzerland AG 2020.

Entities:  

Keywords:  Dyslipidemia; Pakistan; Prevalence; Second NDSP

Year:  2020        PMID: 33520835      PMCID: PMC7843689          DOI: 10.1007/s40200-020-00631-z

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  30 in total

1.  Hypertension in Saudi Arabia.

Authors:  Mansour M Al-Nozha; Moheeb Abdullah; Mohammed R Arafah; Mohamed Z Khalil; Nazeer B Khan; Yaqoub Y Al-Mazrou; Mohammed A Al-Maatouq; Khalid Al-Marzouki; Akram Al-Khadra; Mohammed S Nouh; Saad S Al-Harthi; Maie S Al-Shahid; Abdulellah Al-Mobeireek
Journal:  Saudi Med J       Date:  2007-01       Impact factor: 1.484

2.  Serum LDL cholesterol levels and new onset of arterial hypertension: an 8-year follow-up.

Authors:  Arrigo F G Cicero; Martina Rosticci; Cristina Baronio; Martino Morbini; Angelo Parini; Elisa Grandi; Sergio D'Addato; Claudio Borghi
Journal:  Eur J Clin Invest       Date:  2014-10       Impact factor: 4.686

Review 3.  Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus.

Authors:  Surapon Tangvarasittichai
Journal:  World J Diabetes       Date:  2015-04-15

4.  Prevalence and risk factors associated with the metabolic syndrome and dyslipidemia in White, Black, Amerindian and Mixed Hispanics in Zulia State, Venezuela.

Authors:  Hermes Florez; Eglé Silva; Virginia Fernández; Elena Ryder; Tulio Sulbarán; Gilberto Campos; Gustavo Calmón; Emilio Clavel; Sumaya Castillo-Florez; Ronald Goldberg
Journal:  Diabetes Res Clin Pract       Date:  2005-02-19       Impact factor: 5.602

5.  Prevalence of dyslipidemia and risk factors in Campos dos Goytacazes, in the Brazilian state of Rio de Janeiro.

Authors:  Luiz José de Souza; João Tadeu Damian Souto Filho; Thiago Ferreira de Souza; Aldo Franklin Ferreira Reis; Carlos Gicovate Neto; Diogo Assed Bastos; Vitor Azevedo Côrtes; Félix Elias Barros Chalita; Cláudio Luiz Teixeira
Journal:  Arq Bras Cardiol       Date:  2003-10-09       Impact factor: 2.000

6.  Dyslipidemia patterns among Hispanics/Latinos of diverse background in the United States.

Authors:  Carlos J Rodriguez; Martha L Daviglus; Katrina Swett; Hector M González; Linda C Gallo; Sylvia Wassertheil-Smoller; Aida L Giachello; Yanping Teng; Neil Schneiderman; Gregory A Talavera; Robert C Kaplan
Journal:  Am J Med       Date:  2014-09-03       Impact factor: 4.965

7.  Prevalence and pattern of dyslipidemia in hyperglycemic patients and its associated factors among Pakistani population.

Authors:  Maliha Sarfraz; Sanaullah Sajid; Muhammad Aqeel Ashraf
Journal:  Saudi J Biol Sci       Date:  2016-03-10       Impact factor: 4.219

8.  Prevalence of dyslipidemia in urban and rural India: the ICMR-INDIAB study.

Authors:  Shashank R Joshi; Ranjit Mohan Anjana; Mohan Deepa; Rajendra Pradeepa; Anil Bhansali; Vinay K Dhandania; Prashant P Joshi; Ranjit Unnikrishnan; Elangovan Nirmal; Radhakrishnan Subashini; Sri Venkata Madhu; Paturi Vishnupriya Rao; Ashok Kumar Das; Tanvir Kaur; Deepak Kumar Shukla; Viswanathan Mohan
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

9.  Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients.

Authors:  Jeong Uk Lim; Jae Ha Lee; Ju Sang Kim; Yong Il Hwang; Tae-Hyung Kim; Seong Yong Lim; Kwang Ha Yoo; Ki-Suck Jung; Young Kyoon Kim; Chin Kook Rhee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-08-21

10.  Prevalence of diabetes, pre-diabetes and associated risk factors: second National Diabetes Survey of Pakistan (NDSP), 2016-2017.

Authors:  Abdul Basit; Asher Fawwad; Huma Qureshi; A S Shera
Journal:  BMJ Open       Date:  2018-08-05       Impact factor: 2.692

View more
  3 in total

1.  National high prevalence, and low awareness, treatment and control of dyslipidaemia among people aged 15-69 years in Mongolia in 2019.

Authors:  Supa Pengpid; Karl Peltzer
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

2.  A homozygous variant in the GPIHBP1 gene in a child with severe hypertriglyceridemia and a systematic literature review.

Authors:  Ursa Sustar; Urh Groselj; Sabeen Abid Khan; Saeed Shafi; Iqbal Khan; Jernej Kovac; Barbara Jenko Bizjan; Tadej Battelino; Fouzia Sadiq
Journal:  Front Genet       Date:  2022-08-16       Impact factor: 4.772

3.  Prevalence, awareness, treatment, and control of dyslipidemia and associated factors among adults in Jordan: Results of a national cross-sectional survey in 2019.

Authors:  Supa Pengpid; Karl Peltzer
Journal:  Prev Med Rep       Date:  2022-06-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.